Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://marvinwqlb767730.blogtov.com/19602614/semaglutide-a-potential-solution-for-metabolic-disorders